Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Balinatunfib [1] Balinatunfib[1] Balinatunfib 💬 [2] TNFRSF1A,
TNFRSF1B 💬
[35] Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, NF-kappa B signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TNF signaling pathway, Toxoplasmosis, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, mTOR signaling pathway 💬[2] 96, 97 💬